Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation

Journal of Immunology

Volumn 180, Issue 2, 2008, Pages 727-738

  Carreras, Esther ^a   Turner, Sean ^a   Paharkova Vatchkova, Vladislava ^b,d   Mao, Allen ^b   Dascher, Christopher ^c   Kovats, Susan ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLT3 LIGAND; FULVESTRANT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL SELECTION; CELL SURVIVAL; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; IMMUNITY; IN VIVO STUDY; INFLAMMATION; LANGERHANS CELL; LYMPHOID CELL; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CELL COUNT; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM;

ANIMALS; BONE MARROW CELLS; CELL COUNT; CELL DIFFERENTIATION; DENDRITIC CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYELOID PROGENITOR CELLS;

EID: 40449085440     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.2.727     Document Type: Article

References (79)

1. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
2. Steinman, R. M., and M. C. Nussenzweig. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99: 351-358.
3. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294: 1540-1543.
4. Banchereau, J., V. Pascual, and A. K. Palucka. 2004. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 20: 539-550.
5. O'Lone, R., M. C. Frith, E. K. Karlsson, and U. Hansen. 2004. Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 18: 1859-1875.
6. Nilsson, S., S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J. A. Gustafsson. 2001. Mechanisms of estrogen action. Physiol. Rev. 81: 1535-1565.
7. Dutertre, M., and C. L. Smith. 2000. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J. Pharmacol. Exp. Ther. 295: 431-437.
8. Ren, M. Q., G. Kuhn, J. Wegner, and J. Chen. 2001. Isoflavones, substances with multi-biological and clinical properties. Eur. J. Nutr. 40: 135-146.
9. Ahmed, S. A., B. D. Hissong, D. Verthelyi, K. Donner, K. Becker, and E. Karpuzoglu-Sahin. 1999. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ. Health Perspect. 107(Suppl. 5): 681-686.
10. Hall, J. M., J. F. Couse, and K. S. Korach. 2001. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276: 36869-36872.
11. McDonnell, D. P. 2004. The molecular determinants of estrogen receptor pharmacology. Maturitas 48(Suppl. 1): S7-S12.
12. Frasor, J., J. M. Danes, B. Komm, K. C. Chang, C. R. Lyttle, and B. S. Katzenellenbogen. 2003. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574.
13. Manavathi, B., and R. Kumar. 2006. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J. Cell. Physiol. 207: 594-604.
14. Deroo, B. J., and K. S. Korach. 2006. Estrogen receptors and human disease. J. Clin. Invest. 116: 561-570.
15. Whitacre, C. C., S. C. Reingold, and P. A. O'Looney. 1999. A gender gap in autoimmunity. Science 283: 1277-1278.
16. Igarashi, H., T. Kouro, T. Yokota, P. C. Comp, and P. W. Kincade. 2001. Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc. Natl. Acad. Sci. USA 98: 15131-15136.
17. Marriott, I., and Y. M. Huet-Hudson. 2006. Sexual dimorphism in innate immune responses to infectious organisms. Immunol. Res. 34: 177-192.
18. Kovacs, E. J. 2005. Aging, traumatic injury, and estrogen treatment. Exp. Gerontol. 40: 549-555.
19. Whitacre, C. C. 2001. Sex differences in autoimmune disease. Nat. Immunol. 2: 777-780.
20. Medina, K. L., K. P. Garrett, L. F. Thompson, M. I. Rossi, K. J. Payne, and P. W. Kincade. 2001. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat. Immunol. 2: 718-724.
21. Soldan, S. S., A. I. Alvarez Retuerto, N. L. Sicotte, and R. R. Voskuhl. 2003. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 171: 6267-6274.
22. Grimaldi, C. M., L. Hill, X. Xu, E. Peeva, and B. Diamond. 2005. Hormonal modulation of B cell development and repertoire selection. Mol. Immunol. 42: 811-820.
23. Howell, A. L., S. N. Asin, G. R. Yeaman, and C. R. Wira. 2005. HIV-1 infection of the female reproductive tract. Curr. HIV/AIDS Rep. 2: 35-38.
24. Medina, K. L., and P. W. Kincade. 1994. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. Proc. Natl. Acad. Sci. USA 91: 5382-5386.
25. + lymphoid progenitors. Blood 109: 4825-4931.
26. Harman, B. C., J. P. Miller, N. Nikbakht, R. Gerstein, and D. Allman. 2006. Mouse plasmacytoid dendritic cells derive exclusively from estrogen-resistant myeloid progenitors. Blood 108: 878-885.
27. Nalbandian, G., and S. Kovats. 2005. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen presenting cells. Immunol. Res. 31: 91-106.
28. intermediate dendritic cells from bone marrow precursors. J. Immunol. 172: 1426-1436.
29. Mao, A., V. Paharkova-Vatchkova, J. Hardy, M. M. Miller, and S. Kovats. 2005. Estrogen selectively promotes the differentiation of dendritic cells with characteristics of Langerhans cells. J. Immunol. 175: 5146-5151.
30. Nalbandian, G., V. Paharkova-Vatchkova, A. Mao, S. Nale, and S. Kovats. 2005. The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. J. Immunol. 175: 2666-2675.
31. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7: 19-30.
32. Wu, L., and Y. J. Liu. 2007. Development of dendritic-cell lineages. Immunity 26: 741-750.
33. McKenna, H. J., K. L. Stocking, R. E. Miller, K. Brasel, T. De Smedt, E. Maraskovsky, C. R. Maliszewski, D. H. Lynch, J. Smith, B. Pulendran, et al. 2000. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95: 3489-3497.
34. Vremec, D., G. J. Lieschke, A. R. Dunn, L. Robb, D. Metcalf, and K. Shortman. 1997. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27: 40-44.
35. O'Keeffe, M., H. Hochrein, D. Vremec, J. Pooley, R. Evans, S. Woulfe, and K. Shortman. 2002. Effects of administration of progenipoietin 1: Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99: 2122-2130.
36. high murine dendritic cells in vivo: a comparative analysis with Flt3 ligand. J. Immunol. 165: 49-58.
37. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184: 1953-1962.
38. Mach, N., S. Gillessen, S. B. Wilson, C. Sheehan, M. Mihm, and G. Dranoff. 2000. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60: 3239-3246.
39. Hamilton, J. A. 2002. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23: 403-408.
40. Willeke, P., B. Schluter, H. Schotte, M. Erren, E. Mickholz, W. Domschke, and M. Gaubitz. 2004. Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption. Lupus 13: 257-262.
41. + dendritic cells in vivo. J. Exp. Med. 198: 305-313.
42. D'Amico, A., and L. Wu. 2003. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 198: 293-303.
43. + myeloid progenitors are the main source of Langerhans cells. Blood 107: 1383-1390.
44. Manz, M. G., D. Traver, T. Miyamoto, I. L. Weissman, and K. Akashi. 2001. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97: 3333-3341.
45. Fogg, D. K., C. Sibon, C. Miled, S. Jung, P. Aucouturier, D. R. Littman, A. Cumano, and F. Geissmann. 2006. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311: 83-87.
46. Nikolic, T., M. F. de Bruijn, M. B. Lutz, and P. J. Leenen. 2003. Developmental stages of myeloid dendritic cells in mouse bone marrow. Int. Immunol. 15: 515-524.
47. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174: 6592-6597.
48. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
49. Wilkinson, R. F. 1993. The effect of charcoal/dextran treatment on select serum components. In Art to Science in Tissue Culture, Vol. 12, No. 3/4. Hyclone, Logan, UT, pp. 1-10.
50. Berthois, Y., J. A. Katzenellenbogen, and B. S. Katzenellenbogen. 1986. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA 83: 2496-2500.
51. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92.
52. Qin, Z., G. Noffz, M. Mohaupt, and T. Blankenstein. 1997. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J. Immunol. 159: 770-776.
53. Dascher, C. C., K. Hiromatsu, X. Xiong, M. Sugita, J. E. Buhlmann, I. L. Dodge, S. Y. Lee, C. Roura-Mir, G. F. Watts, C. J. Roy, et al. 2002. Conservation of CD1 intracellular trafficking patterns between mammalian species. J. Immunol. 169: 6951-6958.
54. Divanovic, S., A. Trompette, S. F. Atabani, R. Madan, D. T. Golenbock, A. Visintin, R. W. Finberg, A. Tarakhovsky, S. N. Vogel, Y. Belkaid, et al. 2005. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6: 571-578.
55. Gilliet, M., A. Boonstra, C. Paturel, S. Antonenko, X. L. Xu, G. Trinchieri, A. O'Garra, and Y. J. Liu. 2002. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195: 953-958.
56. Katzenellenbogen, B. S., K. L. Kendra, M. J. Norman, and Y. Berthois. 1987. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 47: 4355-4360.
57. Foster, H. L., J. D. Small, and J. G. Fox. 1983. Normative Biology, Immunology and Husbandry. Academic Press, Orlando.
58. Couse, J. F., and K. S. Korach. 1999. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20: 358-417.
59. Chang, E. C., J. Frasor, B. Komm, and B. S. Katzenellenbogen. 2006. Impact of estrogen receptor β on gene networks regulated by estrogen receptor α in breast cancer cells. Endocrinology 147: 4831-4842.
60. Smithson, G., J. F. Couse, D. B. Lubahn, K. S. Korach, and P. W. Kincade. 1998. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J. Immunol. 161: 27-34.
61. Howell, A., C. K. Osborne, C. Morris, and A. E. Wakeling. 2000. ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer 89: 817-825.
62. Lambert, K. C., E. M. Curran, B. M. Judy, D. B. Lubahn, and D. M. Estes. 2004. Estrogen receptor-α deficiency promotes increased TNF-α secretion and bacterial killing by murine macrophages in response to microbial stimuli in vitro. J. Leukocyte Biol. 75: 1166-1172.
63. Akashi, K., D. Traver, T. Miyamoto, and I. L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197.
64. Karsunky, H., M. Merad, I. Mende, M. G. Manz, E. G. Engleman, and I. L. Weissman. 2005. Developmental origin of interferon-α-producing dendritic cells from hematopoietic precursors. Exp. Hematol. 33: 173-181.
65. Pelayo, R., J. Hirose, J. Huang, K. P. Garrett, A. Delogu, M. Busslinger, and P. W. Kincade. 2005. Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 105: 4407-4415.
66. Yang, G. X., Z. X. Lian, K. Kikuchi, Y. Moritoki, A. A. Ansari, Y. J. Liu, S. Ikehara, and M. E. Gershwin. 2005. Plasmacytoid dendritic cells of different origins have distinct characteristics and function: studies of lymphoid progenitors versus myeloid progenitors. J. Immunol. 175: 7281-7287.
67. Lyman, S. D., and S. E. Jacobsen. 1998. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91: 1101-1134.
68. Feldman, G. M., L. A. Rosenthal, X. Liu, M. P. Hayes, A. Wynshaw-Boris, W. J. Leonard, L. Hennighausen, and D. S. Finbloom. 1997. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood 90: 1768-1776.
69. Veiby, O. P., F. W. Jacobsen, L. Cui, S. D. Lyman, and S. E. Jacobsen. 1996. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential: suppression of apoptosis and counteraction by TNF-α and TGF-β. J. Immunol. 157: 2953-2960.
70. Onai, N., A. Obata-Onai, R. Tussiwand, A. Lanzavecchia, and M. G. Manz. 2006. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J. Exp. Med. 203: 227-238.
71. Laouar, Y., T. Welte, X. Y. Fu, and R. A. Flavell. 2003. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19: 903-912.
72. Bjornstrom, L., and M. Sjoberg. 2002. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol. Endocrinol. 16: 2202-2214.
73. Yamamoto, T., T. Matsuda, A. Junicho, H. Kishi, F. Saatcioglu, and A. Muraguchi. 2000. Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling. FEBS Lett. 486: 143-148.
74. Faulds, M. H., K. Pettersson, J. A. Gustafsson, and L. A. Haldosen. 2001. Cross-talk between ERs and signal transducer and activator of transcription 5 is E2 dependent and involves two functionally separate mechanisms. Mol. Endocrinol. 15: 1929-1940.
75. Leung, K. C., N. Doyle, M. Ballesteros, K. Sjogren, C. K. Watts, T. H. Low, G. M. Leong, R. J. Ross, and K. K. Ho. 2003. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc. Natl. Acad. Sci. USA 100: 1016-1021.
76. Wang, L. H., X. Y. Yang, K. Mihalic, W. Xiao, D. Li, and W. L. Farrar. 2001. Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3. J. Biol. Chem. 276: 31839-31844.
77. Wada, H., Y. Noguchi, M. W. Marino, A. R. Dunn, and L. J. Old. 1997. T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice. Proc. Natl. Acad. Sci. USA 94: 12557-12561.
78. Burnham, K., L. Robb, C. L. Scott, M. O'Keeffe, and K. Shortman. 2000. Effect of granulocyte-macrophage colony-stimulating factor on the generation of epidermal Langerhans cells. J. Interferon Cytokine Res. 20: 1071-1076.
79. Jordan, V. C., S. Gapstur, and M. Morrow. 2001. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J. Natl. Cancer Inst. 93: 1449-1457.